SONOMA PHARMACEUTICALS INC (SNOA)

Company Profile

Sonoma Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Boulder, Colorado and currently employs 172 full-time employees. The company went IPO on 2007-01-26. Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The firm's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.

Company Info

SONOMA PHARMACEUTICALS INC

5445 Conestoga Court, Suite 150

Boulder COLORADO 30189

P: 18007599305

CEO: Amy Trombly

Employees: 10

Website: https://sonomapharma.com/